View Larger Image Fibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology, Fibrotic Disease, and Cardiovascular Disease Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer Informa Connect: Radiopharmaceuticals and Imaging Digital Conference March 14, 2023 Download the Presentation sofie_c557hm2025-11-04T00:28:35+00:0014, Mar 2023|Presentations| Share This Story, Choose Your Platform! FacebookXLinkedInPinterest Related Posts FAP in Focus – Oncology and Horizons Beyond Cancer Gallery FAP in Focus – Oncology and Horizons Beyond Cancer 31, May 2026 Addressing Unmet Needs with [18F]FAPI-74 Gallery Addressing Unmet Needs with [18F]FAPI-74 4, Feb 2026 A Target of Opportunity – Shaping the Future of FAPI Gallery A Target of Opportunity – Shaping the Future of FAPI 22, Jun 2025 [68Ga]FAPI-46 Phase 2 clinical development updates Gallery [68Ga]FAPI-46 Phase 2 clinical development updates 9, Jun 2024 Current State of FAP Targeting Radioligands Gallery Current State of FAP Targeting Radioligands 30, May 2024
![Addressing Unmet Needs with [18F]FAPI-74](https://sofie.com/wp-content/uploads/2026/02/FAPI-500x383.jpg)
![[68Ga]FAPI-46 Phase 2 clinical development updates](https://sofie.com/wp-content/uploads/2024/06/FAPI-46-Phase-2-clinical-development-updates-500x383.png)
